ArticleEClinicalMedicine2023

Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial.

Vivianne C G Tjan-Heijnen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.